Chan Keith Syson, Carbajal Steve, Kiguchi Kaoru, Clifford John, Sano Shigetoshi, DiGiovanni John
Department of Carcinogenesis, The University of Texas, M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957, USA.
Cancer Res. 2004 Apr 1;64(7):2382-9. doi: 10.1158/0008-5472.can-03-3197.
In the present study, we have investigated the possible role of signal transducers and activators of transcription (STATs), particularly Stat3, in mouse skin tumor promotion and multistage carcinogenesis. Stat1, Stat3, and Stat5 were activated in mouse epidermis after treatment with different classes of tumor promoters, including 12-O-tetradecanoylphorbol-13-acetate (TPA), okadaic acid, and chrysarobin. In addition, Stat1, Stat3, and Stat5 were constitutively activated in skin tumors generated by the two-stage carcinogenesis regimen using 7,12-dimethylbenz(a)anthracene as initiator and TPA as promoter. Several approaches were used to examine the possible role of epidermal growth factor receptor (EGFR) in modulating Stat3 activity during tumor promotion. In primary cultures of mouse keratinocytes, addition of exogenous EGF led to activation of Stat3 as shown by an elevation in tyrosine phosphorylation and nuclear translocation. In epidermis of transgenic mice expressing transforming growth factor alpha under control of the keratin 14 promoter, Stat3 was constitutively activated. Abrogation of EGFR function in mouse epidermis using an EGFR kinase inhibitor or by overexpressing a dominant negative form of EGFR led to a reduction in Stat3 activation in response to TPA treatment. Immunoprecipitation analyses using lysates from TPA-treated epidermis and skin papillomas showed enhanced interaction between the EGFR and Stat3. Finally, Stat3 deficiency in mouse epidermis significantly reduced the proliferative response after TPA treatment. Collectively, the current results suggest that Stat3 activation may be a critical event during mouse skin tumor promotion, possibly through regulation of keratinocyte proliferation. In addition, Stat3 activation in tumor promoter-treated epidermis and in skin papillomas may occur, at least in part, via interaction with and phosphorylation by the EGFR. Finally, constitutive activation of Stat3 in both papillomas and squamous cell carcinomas suggest a role in both the development of autonomous growth and the progression of epithelial tumors in mouse skin.
在本研究中,我们探究了信号转导及转录激活因子(STATs),尤其是Stat3,在小鼠皮肤肿瘤促进及多阶段致癌过程中的可能作用。在用不同种类的肿瘤促进剂处理后,包括12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)、冈田酸和柯桠素,Stat1、Stat3和Stat5在小鼠表皮中被激活。此外,在以7,12 - 二甲基苯并(a)蒽为引发剂、TPA为促进剂的两阶段致癌方案所产生的皮肤肿瘤中,Stat1、Stat3和Stat5持续被激活。我们采用了几种方法来研究表皮生长因子受体(EGFR)在肿瘤促进过程中调节Stat3活性的可能作用。在小鼠角质形成细胞的原代培养中,添加外源性表皮生长因子(EGF)导致Stat3激活,表现为酪氨酸磷酸化增加和核转位。在角蛋白14启动子控制下表达转化生长因子α的转基因小鼠的表皮中,Stat3持续被激活。使用EGFR激酶抑制剂或通过过表达EGFR的显性负性形式消除小鼠表皮中的EGFR功能,导致对TPA处理的Stat3激活减少。使用TPA处理的表皮和皮肤乳头瘤的裂解物进行免疫沉淀分析,显示EGFR与Stat3之间的相互作用增强。最后,小鼠表皮中Stat3缺陷显著降低了TPA处理后的增殖反应。总体而言,目前的结果表明Stat3激活可能是小鼠皮肤肿瘤促进过程中的关键事件,可能是通过调节角质形成细胞增殖。此外,在肿瘤促进剂处理的表皮和皮肤乳头瘤中Stat3激活可能至少部分是通过与EGFR相互作用并被其磷酸化而发生。最后,Stat3在乳头瘤和鳞状细胞癌中的持续激活表明其在小鼠皮肤自主性生长的发展和上皮肿瘤进展中均起作用。